Aller au contenu principal
Profil bibliographique

Maria Atanasova Radanova

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

69Publications signalées
618Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Complement system in diseasesSystemic Lupus Erythematosus ResearchMicroRNA in disease regulationRenal Diseases and GlomerulopathiesCircular RNAs in diseases

Les publications récentes

Accès ouvert 2026 article OpenAlex

Tumour cell-intrinsic complement C1r and C1s regulate cancer cell fitness and shape the immune microenvironment in triple-negative breast cancer

Andrea Minery, Maria Atanasova Radanova, Lou Segarra, Julie Peliconi et autres

Emerging evidence positions tumour cell-intrinsic complement proteins as regulators of cancer cell behaviour and immune crosstalk, yet their role in triple-negative breast cancer (TNBC) remains undefined. Here, transcriptomic profiling across breast cancer molecular subtypes reveals that C1R, C1S and C3 are preferentially …

fr, bg (code pays fourni par la source)

0 citations Cellular and Molecular Life Sciences
Accès ouvert 2025 article OpenAlex

113eP H3K27me3 is a potential biomarker for negative prognosis and low OS in NSCLC

Nikolay Evgeniev, Maria Atanasova Radanova, I.S. Donev, Rumelia Nikolaeva et autres

Nucleosomes play a critical role in the regulation of gene expression and maintaining chromatin structure. In oncology, alterations in histone modifications within nucleosomes have been implicated in the pathogenesis of various cancers, including non-small cell lung cancer (NSCLC). This study investigates the …

bg, ru (code pays fourni par la source)

0 citations ESMO Open
Accès ouvert 2025 article OpenAlex

Clinically Based Cetuximab Re-Challenge in Patients with RAS Wild-Type Metastatic Colorectal Cancer and Retrospective Analysis of Liquid Biopsies—Preliminary Data

Zhasmina Mihaylova, Stoyan Bichev, Alexey Slavkov Savov, Maria Atanasova Radanova

Background: Anti-EGFR therapy, combined with chemotherapy, represents the standard therapeutic approach for triple wild-type (KRAS/NRAS and BRAF), left-sided, microsatellite stable (MSS) metastatic colorectal cancer (mCRC). However, acquired resistance develops in approximately 50% of patients. This study evaluated the efficacy of anti-EGFR therapy …

bg (code pays fourni par la source)

0 citations Gastrointestinal Disorders
Accès ouvert 2025 article OpenAlex

Complement and the hallmarks of cancer

Mikel Rezola Artero, Andrea Minery, Leon Nedelcev, Maria Atanasova Radanova et autres

The hallmarks of cancer are a set of traits that normal cells acquire during their transformation into malignancy. Among the biological processes influencing these hallmarks, the innate immune complement system plays a critical role. It can operate canonically-in blood and tissues-via phagocytosis, …

fr, bg (code pays fourni par la source)

24 citations Seminars in Immunology
Accès ouvert 2025 article OpenAlex

Selected microRNAs as Potential Diagnostic Biomarkers in Polycystic Ovary Syndrome in Adolescent Girls

Vilhelm Mladenov, Maria Atanasova Radanova, Sonya Galcheva, Violeta Iotova

Background: Polycystic ovary syndrome (PCOS) is the most common hyperandrogenic disorder in reproductive age women. Identifying new biomarkers with high specificity and sensitivity is crucial for diagnosing and monitoring the disease. MiRNAs correlate with PCOS-related comorbidities, suggesting their potential as biomarkers. This …

bg (code pays fourni par la source)

3 citations Applied Sciences
Accès ouvert 2024 article OpenAlex

Anti-factor H autoantibodies in patients with lupus nephritis

Galya Mihaylova, Vasil V. Vasilev, M Kosturkova, Mariana Petkova et autres

Lupus nephritis (LN) is a disease marked by autoantibodies against complement components. Autoantibodies against negative complement regulator factor H (anti-FH) are prevalent in aHUS, are associated with deletion of factor H-related protein 1 (FHR1) gene, and have overt functional consequences. They are …

bg (code pays fourni par la source)

0 citations Medicina Clínica (English Edition)
Accès ouvert 2024 article OpenAlex

Polycystic ovary syndrome in adolescents — controversial diagnostic criteria and potential new biomarkers

Vilhelm Mladenov, Maria Atanasova Radanova, Violeta Iotova

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting reproductive age women. The etiology and pathogenesis of the syndrome are still not fully understood, but insulin resistance and hyperinsulinemia, neuroendocrine dysfunction leading to elevated luteinizing hormone (LH) levels, …

bg (code pays fourni par la source)

0 citations Scripta Scientifica Medica
Accès ouvert 2024 article OpenAlex

Anti-factor H autoantibodies in patients with lupus nephritis

Galya Mihaylova, Vasil V. Vasilev, M Kosturkova, Mariana Petkova et autres

Lupus nephritis (LN) is a disease marked by autoantibodies against complement components. Autoantibodies against negative complement regulator factor H (anti-FH) are prevalent in aHUS, are associated with deletion of factor H-related protein 1 (FHR1) gene, and have overt functional consequences. They are …

bg (code pays fourni par la source)

4 citations Medicina Clínica
Accès ouvert 2024 article OpenAlex

Clinical Relevance of Anti-C3 and Anti-C4 Autoantibodies in Lupus Nephritis

Vasil V. Vasilev, Mikel Rezola Artero, M Petkova, Galya Mihaylova et autres

Introduction: Complement system overactivation is pivotal in lupus nephritis (LN) pathophysiology. Considering that anti-C3 autoantibodies play a significant role in LN pathophysiology, we explored them as disease activity biomarkers and compared them to the ones against the homologous protein, C4. Methods: = …

bg, fi, fr (code pays fourni par la source)

9 citations Kidney International Reports
Accès ouvert 2023 article OpenAlex

Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting

R. Gencheva, Mirela Petrova, Petya Kraleva, Savina Petrova Hadjidekova et autres

BACKGROUND AND AIMS: In approximately 40% of patients with HER2-negative/HR-positive breast cancer tumors, the PIK3CA gene is mutated. Despite this, clinical outcomes vary between studies in this cohort. We aimed to ascertain the prevalence of PIK3CA mutations in patients with metastatic HR+/HER2- …

bg (code pays fourni par la source)

2 citations Cancer Reports
Accès ouvert 2023 book-chapter OpenAlex

Transcribed-Ultra Conserved Regions (T-UCRs) a New Light on a Dark Matter

Maria Atanasova Radanova

Transcribed Ultra-Conserved Regions (T-UCRs) are a novel class of long non-coding RNAs derived from Ultra-Conserved Regions (UCRs) of DNA. The discovery of cancer-specific mutations in UCRs and their location in cancer-associated genomic regions suggests that T-UCRs also play a role in carcinogenesis. …

bg (code pays fourni par la source)

0 citations Genetics.
Accès ouvert 2023 article OpenAlex

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer

Maria Atanasova Radanova, Galya Mihaylova, George S Stoyanov, Vyara Draganova et autres

RAS somatic variants are predictors of resistance to anti-EGFR therapy for colorectal cancer (CRC) and affect the outcome of the disease. Our study aimed to evaluate the frequency of RAS, with a focus on KRAS variants, and their association with tumor location …

bg (code pays fourni par la source)

7 citations International Journal of Molecular Sciences

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.